— Expands Potential Serviceable Market to Include Companies Requiring Certification — SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that its quality management systems for manufacturing its next-generation sequencing (NGS) Target Enrichment Panels received International Organization for Standardization(ISO) 9001:2015 and 13485:2016 certification1, the latter […]
Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that the claims to a single molecule sequencing process were unsupported […]
Based on the content of TruSight Oncology 500, the proposed in vitro diagnostic will receive prioritized review and resources Today, Illumina announces that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its pan-cancer assay. Currently in development, with plans to be marketed as TruSight™ Oncology Comprehensive, the assay is based on […]
BEVERLY, Mass. – LexaGene Holdings Inc.(otcqb:LXXGF)(LXG) (the “Company”), a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers, announced today that the Company has formed a scientific advisory board (SAB) to assist the Company in product positioning and its go-to-market strategy. The SAB is comprised of key opinion leaders in the Company’s […]
Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes Service expansion parallels requirements of immunology-based research in drug discovery Cambridge, UK, 21 January, 2019: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its […]
Partnership will leverage BenchSci’s artificial intelligence to help researchers find the right antibodies faster than ever before CARLSBAD, CALIF. Active Motif, the industry leader in developing and delivering tools to enable epigenetics and gene regulation research, and BenchSci, a life science machine learning startup backed by Google’s AI fund, have announced a new partnership to […]
(ANN ARBOR, Mich.) Swift Biosciences today announced the launch of its Swift Amplicon 16S+ITS Panel, facilitating routine NGS analysis of complex microbial samples (e.g. bacteria, archaea, fungi) using a single, multiplexed primer pool targeting the 16S rRNA gene (all variable regions, V1-V9) and ITS1 and ITS2 for fungi. With a comprehensive yet targeted library approach […]
HTG EdgeSeq Reveal is a new software product to analyze HTG EdgeSeq Precision Immuno‑Oncology Panel data TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch of the HTG EdgeSeq Reveal. HTG EdgeSeq Reveal is a powerful software product that streamlines […]
Illumina to collaborate with the Frederick National Laboratory for Cancer Research The measurement of cancer mutations in blood and other fluids has the capability to transform how patients are treated and monitored. Genomic assays, like Illumina’s TruSight™ Oncology 500 (TSO 500), have the potential to provide critical information to guide cancer care and monitor treatment over time. However, […]
NimaGen B.V. today announce the agreement of licensing terms for a novel One Step PCR technology employing reverse complement probes from the Salisbury NHS Foundation Trust, of Salisbury, United Kingdom. Today we proudly announce the agreement of licensing terms for a novel One Step PCR technology employing reverse complement probes from the Salisbury NHS Foundation Trust, of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
